Compass Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,967
Closed -$1.01M 30
2023
Q1
$1.01M Sell
14,967
-1,690
-10% -$109K 1.29% 23
2022
Q4
$825K Buy
16,657
+3,131
+23% +$128K 1.11% 25
2022
Q3
$439K Buy
13,526
+1,841
+16% +$75.9K 0.65% 55
2022
Q2
$460K Buy
11,685
+996
+9% +$53.3K 0.63% 52
2022
Q1
$747K Buy
10,689
+4,194
+65% +$307K 0.83% 38
2021
Q4
$506K Buy
+6,495
New +$573K 0.56% 69

Other funds holding EXAS

Compass Financial Advisors's EXAS Position: Q2 2023 in Review

Compass Financial Advisors sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 14,967 shares — an estimated $1.01M sold.

Compass Financial Advisors first reported a position in EXAS in Q4 2021 and held it in 6 quarters. The position peaked at $1.01M in Q1 2023. 652 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Compass Financial Advisors reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • Compass Financial Advisors sold 14,967 Exact Sciences shares in Q2 2023, an estimated $1.01M.
  • Compass Financial Advisors first reported a position in Exact Sciences in Q4 2021 and held it in 6 quarters.
  • Compass Financial Advisors's Exact Sciences position peaked at $1.01M in Q1 2023.
  • 652 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.